We are pleased to announce Sarvajna Dwivedi as a speaker at the 2018 TiEcon Florida conference.
Be with us, when Sarvajna Dwivedi, Co-Founder & Chief Scientific Officer, Pearl Therapeutics. Pearl was founded in 2006, with a mission to develop differentiated therapeutics for respiratory disease conditions prevalent worldwide, including chronic obstructive pulmonary disease (COPD). Sarvajna has extensive experience in drug development at GSK, Dura Pharmaceuticals Inc. (Dura), Alkermes plc. (Alkermes), and Nektar Therapeutics (Nektar). He was involved in the development of over 40 molecules in various therapeutic classes and dosage forms from discovery to commercialization. At Nektar, he was the Director of Product Development, responsible for new product identification, design, planning, and development efforts.
Join us! Mark your calendars for March 31, 2018. We bring together a mix of startup founders, aspiring entrepreneurs, angel investors, venture capitalists and corporate executives. Entrepreneurs give invaluable advice. Investors and domain experts dish on the latest trends in industries and technologies.
Register at TiEconFL.com.